NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
Closed Posted
- Opportunity number
- PAR-24-316
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
-
- 93.398 Cancer Research Manpower
- Funding instrument
- Grant
- Categories
-
- Education
- Health
- Eligible applicants
-
- County Governments
- For Profit Organizations
- State Governments
- Special District Governments
- Public or Indian Housing Auth.
- Higher Education Inst. (Public)
- City/Township Governments
- Tribal Governments (Federally Recognized)
- Higher Education Inst. (Private)
- Non-501(c)(3) Nonprofits
- Tribal Organizations (Not Federally Recognized)
- Independent School Districts
- 501(c)(3) Nonprofits
- Other
- Small Businesses
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
Paragraph 1:
This Funding Opportunity Announcement (FOA) from the National Institutes of Health (NIH) is for the NCI Mentored Research Scientist Development Award to Promote Diversity (K01), which provides salary and research support to enhance the diversity of the NCI-funded cancer research workforce. The grant supports "protected time" for intensive research career development under the guidance of an experienced mentor for eligible individuals from diverse backgrounds, including underrepresented groups, proposing research that does not involve leading an independent clinical trial. The application deadline is November 28, 2024.
Paragraph 2:
The grant is part of the NIH's Cancer Research Manpower program (CFDA 93.398), which typically provides Project Grants ranging from $35,000 to $240,000 per award with durations of 2-4 years. The awards support research and training activities aimed at developing cancer research capacity and preparing the next generation of cancer investigators at eligible institutions throughout the United States.
Synopsis
2 versions
Update #2 · Latest ·
This Funding Opportunity Announcement (FOA) is a continuation of the NCI Mentored Research Scientist Development Award to Promote Diversity (K01) to enhance the diversity of thought in the NCI-funded cancer research workforce by supporting eligible individuals from diverse backgrounds, including groups that have been shown to be nationally underrepresented in the biomedical, behavioral, social and clinical sciences. This FOA provides salary and research support for a sustained period of "protected time" for intensive research career development under the guidance of an experienced mentor.This FOA is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary study to an ongoing clinical trial as lead investigator, should apply to the companion FOA.
Update #1 ·
This Funding Opportunity Announcement (FOA) is a continuation of the NCI Mentored Research Scientist Development Award to Promote Diversity (K01) to enhance the diversity of thought in the NCI-funded cancer research workforce by supporting eligible individuals from diverse backgrounds, including groups that have been shown to be nationally underrepresented in the biomedical, behavioral, social and clinical sciences. This FOA provides salary and research support for a sustained period of "protected time" for intensive research career development under the guidance of an experienced mentor.This FOA is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary study to an ongoing clinical trial as lead investigator, should apply to the companion FOA.
Files
| File | Type | Posted |
|---|---|---|
| PAR-24-316-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity